Clinical Trials Logo

Filter by:
NCT ID: NCT03996369 Completed - Ulcerative Colitis Clinical Trials

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

ELEVATE UC 12
Start date: September 15, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of etrasimod on clinical remission in participants with moderately to severely active ulcerative colitis (UC).

NCT ID: NCT03995108 Active, not recruiting - WHIM Syndrome Clinical Trials

Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome

Start date: October 24, 2019
Phase: Phase 3
Study type: Interventional

This study has a double-blind, Randomized Placebo-Controlled Period and an Open-Label Period. The primary objective of the Randomized Placebo-Controlled Period is to demonstrate the efficacy of mavorixafor in participants with WHIM syndrome as assessed by increasing levels of circulating neutrophils compared with placebo, and relative to a clinically meaningful threshold. The primary objective of the Open-Label Period is to evaluate the safety and tolerability of mavorixafor in participants with WHIM syndrome. Participants are allowed to continue treatment in the Open-Label Period, if regionally applicable, until mavorixafor becomes commercially available, or until the study is terminated by the Sponsor.

NCT ID: NCT03994874 Not yet recruiting - Clinical trials for Congestive Heart Failure

Peritoneal Ultrafiltration in Cardio Renal Syndrome.

PURE
Start date: July 2024
Phase: Phase 1/Phase 2
Study type: Interventional

Randomized, controlled, unblinded, adaptive design clinical trial to evaluate the safety and efficacy of PolyCore (Polydextrin, L-Carnitine, D-xylitol) peritoneal ultrafiltration (PUF) in patients with heart failure and reduced ejection fraction (HFrEF).

NCT ID: NCT03994627 Available - Soft Tissue Sarcoma Clinical Trials

Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma

Start date: n/a
Phase:
Study type: Expanded Access

The purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of soft tissue sarcoma (STS).

NCT ID: NCT03994601 Active, not recruiting - Advanced Cancer Clinical Trials

An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers

Start date: September 6, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether BMS-986288 both by itself and in combination with Nivolumab is safe and tolerable in the treatment of select advanced solid tumors.

NCT ID: NCT03994471 Recruiting - Clinical trials for End Stage Renal Disease

Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

ELIXIR
Start date: December 14, 2022
Phase: Phase 3
Study type: Interventional

Randomized, controlled, parallel groups, open-label, blinded end-point assessment, multicenter study, comparing the effects of a low glucose peritoneal dialysis solution, XyloCore, to glucose solutions (Physioneal, Fixioneal, Dianeal, Balance, Bicavera, Bicanova or Equibalance) only regimen, in patients with End-Stage Renal Disease (ESRD) receiving Continuous Ambulatory Peritoneal Dialysis (CAPD), over a 6-month study period.

NCT ID: NCT03994432 Recruiting - Endometriosis Clinical Trials

Effect of Mediterranean Diet and Physical Activity in Patients With Endometriosis

PHAMEDENDO
Start date: January 10, 2019
Phase: N/A
Study type: Interventional

The main aim of this study is to evaluate whether a dietary recommendation based on the Mediterranean diet's principles associated with a regular aerobic physical activity, according to the "7 minutes workout", may improve pain symptoms in patients with symptomatic endometriosis (pelvic pain with numerical rating scale, NRS ≥ 4), in therapy with estrogen-progestins or progestins.

NCT ID: NCT03994328 Completed - Parkinson's Disease Clinical Trials

An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD

SUCCESS
Start date: December 3, 2019
Phase:
Study type: Observational

The purpose of this study is to evaluate how safinamide, rasagiline and other SoC drugs are associated with the quality of life of PD patients by means of the Parkinson's Disease Questionnaire (PDQ)-39 items.

NCT ID: NCT03993067 Completed - Surgery Clinical Trials

Hemopatch as a Tool to Prevent Biliary Fistula in Liver Surgery.

Start date: November 15, 2018
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the use of Hemopatch to prevent biliary fistula in patients submitted to surgery for malignancy.

NCT ID: NCT03992859 Recruiting - Breast Cancer Clinical Trials

Continuous Serrates Plane Block in Axillary Dissection

Start date: June 13, 2018
Phase: N/A
Study type: Interventional

Patients undergone to axillary dissection during breast surgery with a PECS I, II block will be randomized to receive either a serratus plane continuous local anesthetic infusion through a multiple hole catheter or nothing. Both groups will receive a patient controlled analgesia with morphine.